Evidence map›Paper›PMID 41769349›Full record

ArticleFrontiers in cellular and infection microbiology2026

Epidemiology, clinical treatment and outcomes, susceptibility patterns and genotypic analysis of 214

Xiaogai Li, Cailin Liu, Yinyin Hu, Hui Xu, Haijun Li, Jingjing Sun, Xiangyang Chen, Yujuan Meng, Nan Zhang, Gongchang Li and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. When metagenomic next-generation sequencing detectsFrontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiaogai LiDepartment of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Cailin LiuDepartment of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yinyin HuDepartment of Clinical laboratory, Nanyang Central Hospital, Nanyang, Henan, China.
Hui XuDepartment of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Haijun LiDepartment of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Jingjing SunDepartment of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xiangyang ChenDepartment of Clinical laboratory, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, Henan, China.
Yujuan MengDepartment of Clinical laboratory, Luoyang Central Hospital, Luoyang, Henan, China.
Nan ZhangDepartment of Clinical laboratory, The Fifteenth People's Hospital of Zhengzhou, Zhengzhou, Henan, China.
Gongchang LiDepartment of Clinical laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xiuping LeiDepartment of Clinical laboratory, Xiangcheng City Traditional Chinese Medicine Hospital, Zhoukou, Henan, China.
Limin GuoDepartment of Clinical laboratory, Xinxiang Central Hospital, Xinxiang, Henan, China.
Juhua ChenDepartment of Clinical laboratory, Xinyang Maternal and Child Health Care Hospital, Xinyang, Henan, China.
Wanhai WangDepartment of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to investigate the epidemiology, clinical treatment and outcomes, antimicrobial resistance profiles and genotypic analysis of 214 Methods: Through retrospective analysis of hospitalized patients with nocardiosis, the epidemiological characteristics of 214 Results: Of all strains, 74.8% were collected from lower respiratory tract specimens, and Conclusion: This study provides a comprehensive evaluation of the epidemiology, phenotypic and genotypic profiles, and clinical treatment of

Indexed as

Anti-Bacterial AgentsGenotypeNocardiaNocardia InfectionsAdultChinaDrug Resistance, BacterialFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedRetrospective StudiesTreatment OutcomeTrimethoprim, Sulfamethoxazole Drug CombinationVirulence FactorsAnti-Bacterial AgentsTrimethoprim, Sulfamethoxazole Drug CombinationVirulence Factorsantibiotic resistanceepidemiologygenotypingNocardiaoutcomeswhole genome sequencing

Identifiers

PMID41769349
PMCPMC12945825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.